Atlas Trials

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong

Clinical trial NCT05254236 · WITHDRAWN

Trial details

NCT number
NCT05254236
Sponsor
Sinovac Research and Development Co., Ltd.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2022-02-10
Primary completion
2022-03-10
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.